Search Results - "tyrosine kinase"

Experimental Pharmacological Management of Psoriasis by Campione E, Cosio T, Di Prete M, Lanna C, Dattola A, Bianchi L

Connect to this object online.

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case... by Juping Zhao, Kun Dai, Jialing Xie, Chen Fang, Na Chen, Jun Dai, Danfeng Xu

Connect to this object online.

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential? by El Darsa H, El Sayed R, Abdel-Rahman O

Connect to this object online.

NTRK-fusion associated sarcoma: Identification of two cases with a distinct perineurioma-like pattern by Vanessa Young, Daniel Wong, Max Yan, Fiona Maclean

Connect to this object online.

Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours by Yuehua Li, Chengjiang Wei, Wei Wang, Qingfeng Li, Zhi‐Chao Wang

Connect to this object online.

KIT gene mutation causing piebaldism associated with multiple Café Au-Lait like macules and freckling: Delineating a cause of this coexistence by Shibhani S Hegde, Sahana M Srinivas, Nijaguna Nanjundappa

Connect to this object online.

EGFR mutation testing in non-small cell lung cancer (NSCLC) by Fouad Al Dayel

Connect to this object online.

Ponatinib modulates the metabolic profile of obese mice by inhibiting adipose tissue macrophage inflammation by Zhuomiao Lin, Xiaochun Lin, Xiaochun Lin, Ying Lai, Congcong Han, Xinran Fan, Jie Tang, Shiqi Mo, Jiahui Su, Sijia Liang, Sijia Liang, Jinyan Shang, Xiaofei Lv, Siwan Guo, Ruiping Pang, Jiaguo Zhou, Jiaguo Zhou, Jiaguo Zhou, Jiaguo Zhou, Jiaguo Zhou, Tingting Zhang, Tingting Zhang, Tingting Zhang, Feiran Zhang, Feiran Zhang

Connect to this object online.

Selective use of vandetanib in the treatment of thyroid cancer by Fallahi P, Di Bari F, Ferrari SM, Spisni R, Materazzi G, Miccoli P, Benvenga S, Antonelli A

Connect to this object online.

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer by Chilà G, Guarini V, Galizia D, Geuna E, Montemurro F

Connect to this object online.

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia by N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov

Connect to this object online.

Small Molecule Induced FLT3 Degradation by Sun-Young Han

Connect to this object online.

Imatinib-induced exacerbation of psoriasis in a patient with recurrent dermatofibrosarcoma protuberans: A case report and review of the literature by Hsiao-Yu Lin, Chung-Hao Hsu, Shih-Tsung Cheng, Chung-Hsing Chang

Connect to this object online.

Molecular targets in cancer therapy: the Ron approach by Serena Germano, Giovanni Gaudino

Connect to this object online.

Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study by Satoshi Shinohara, Rei Sunami, Mayuko Kasai, Genki Yasuda, Yuzo Uchida

Connect to this object online.

Treating malignant melanoma when a rare BRAF V600M mutation is present: case report and literature review by Popescu Andrei, Haidar Andrei, Anghel Rodica Maricela

Connect to this object online.

Molecular targets in cancer therapy: the Ron approach by Serena Germano, Giovanni Gaudino

Connect to this object online.

A case with psoriasis-like lesions induced by olmutinib (HM61713) while treating epidermal growth factor receptor T790M mutant advanced lung adenocarcinoma by Chu-Ju Hung, Po-Ju Lai, Jen-Jung Cheng, Shiow-Jiuan Wey, Yu-Ping Hsiao, Ming-Fang Wu

Connect to this object online.

The role of RICTOR amplification in targeted therapy and drug resistance by Deze Zhao, Man Jiang, Xiaochun Zhang, Helei Hou

Connect to this object online.

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms by Gregor Hoermann, Georg Greiner, Peter Valent

Connect to this object online.